ESPERION THERAPEUTICS

Esperion Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update

22 Feb 2022 06:00:02 By Nasdaq GlobeNewswire

Esperion to Report Fourth Quarter and Full Year 2021 Financial Results February 22, 2022

08 Feb 2022 07:00:02 By Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

28 Jan 2022 16:00:00 By Nasdaq GlobeNewswire

Esperion Provides Preliminary Fourth Quarter 2021 Financial Results and CLEAR Outcomes Program Update

11 Jan 2022 07:00:02 By Nasdaq GlobeNewswire

Esperion to Participate in Upcoming Virtual J.P. Morgan 40th Annual Healthcare Conference

06 Jan 2022 07:00:01 By Nasdaq GlobeNewswire

Esperion Appoints Benjamin O. Looker as General Counsel

04 Jan 2022 07:00:02 By Nasdaq GlobeNewswire

Esperion Announces Closing of $225 Million Public Offering

07 Dec 2021 15:05:00 By Nasdaq GlobeNewswire

Esperion Announces Pricing of $225 Million Public Offering

02 Dec 2021 22:40:00 By Nasdaq GlobeNewswire

Esperion Announces Proposed Public Offering

02 Dec 2021 16:00:00 By Nasdaq GlobeNewswire

Esperion Presents Important New Science Highlighting Potential Benefits of NEXLETOL® (bempedoic acid) Tablets at American Heart Association Scientific Sessions 2021

12 Nov 2021 06:00:01 By Nasdaq GlobeNewswire

Esperion Reports Third Quarter 2021 Financial Results and Provides Company Update

02 Nov 2021 06:00:01 By Nasdaq GlobeNewswire

Esperion to Present Key Science at the American Heart Association Scientific Sessions 2021

01 Nov 2021 15:01:00 By Nasdaq GlobeNewswire

Esperion Announces the Appointment of Seth H.Z. Fischer to its Board of Directors

01 Nov 2021 06:00:00 By Nasdaq GlobeNewswire

Esperion to Participate in Upcoming Virtual Investor Conference

27 Oct 2021 15:01:00 By Nasdaq GlobeNewswire

ESPERION Announces Agreement to Exchange $15 Million in Principal Amount of its 4.00% Convertible Senior Subordinated Notes due 2025 for Common Stock

25 Oct 2021 06:00:00 By Nasdaq GlobeNewswire

ESPERION Announces Plan for Transformative Long-Term Growth

18 Oct 2021 06:00:01 By Nasdaq GlobeNewswire

Esperion to Report Third Quarter 2021 Financial Results November 2, 2021

12 Oct 2021 07:00:02 By Nasdaq GlobeNewswire

ESPERION to Host Investor Webinar on the Current Landscape and Future Directions in the Treatment of Elevated Cholesterol

07 Sep 2021 15:01:00 By Nasdaq GlobeNewswire

ESPERION Reports Second Quarter 2021 Financial Results and Provides Company Update

03 Aug 2021 06:00:01 By Nasdaq GlobeNewswire

Esperion to Participate in Upcoming Virtual Investor Conference

27 Jul 2021 07:00:02 By Nasdaq GlobeNewswire